Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
The American Journal of the Medical Sciences
|
February 24, 2001
Reversible sequestration of nitric oxide by hemoglobin during hemodialysis in end-stage renal disease
E S Kang, D E Miles, M T Tevlin, et al.
Clinical Transplantation
|
August 1, 1994
Factors affecting erythropoietin production and correction of anemia in kidney transplant recipients
L W Moore, S O Smith, R P Winsett, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 1, 1991
Evaluation of hemodialysis patients treated with erythropoietin
S R Acchiardo, B P Quinn, L W Moore, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
July 1, 1992
Inadequate dialysis increases gross mortality rate
S R Acchiardo, K W Hatten, M J Ruvinsky, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|
January 11, 1991
Evaluation of CAPD prescription
S R Acchiardo, A P Kraus, P A Kaufman, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|
January 11, 1992
Urea kinetics evaluation of hemodialysis and CAPD patients
S R Acchiardo, A P Kraus, G LaHatte, et al.
Proceedings of the Clinical Dialysis and Transplant Forum
|
January 1, 1974
Experience with hemodialysis and renal transplantation in patients with malignant hypertension
S R Acchiardo, W D Black, L Britt, et al.
The American Journal of the Medical Sciences
|
March 1, 1997
Hypotension during hemodialysis: role for nitric oxide
E S Kang, S R Acchiardo, Y B Wang, et al.
The Journal of Laboratory and Clinical Medicine
|
June 13, 2000
Normal circulating adult human red blood cells contain inactive NOS proteins
E S Kang, K Ford, G Grokulsky, et al.
Clinical Nephrology
|
October 30, 2001
A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease
J Lindberg, K J Martin, E A González, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
The American Journal of the Medical Sciences
|
February 24, 2001
Reversible sequestration of nitric oxide by hemoglobin during hemodialysis in end-stage renal disease
E S Kang, D E Miles, M T Tevlin, et al.
Clinical Transplantation
|
August 1, 1994
Factors affecting erythropoietin production and correction of anemia in kidney transplant recipients
L W Moore, S O Smith, R P Winsett, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 1, 1991
Evaluation of hemodialysis patients treated with erythropoietin
S R Acchiardo, B P Quinn, L W Moore, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
July 1, 1992
Inadequate dialysis increases gross mortality rate
S R Acchiardo, K W Hatten, M J Ruvinsky, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|
January 11, 1991
Evaluation of CAPD prescription
S R Acchiardo, A P Kraus, P A Kaufman, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|
January 11, 1992
Urea kinetics evaluation of hemodialysis and CAPD patients
S R Acchiardo, A P Kraus, G LaHatte, et al.
Proceedings of the Clinical Dialysis and Transplant Forum
|
January 1, 1974
Experience with hemodialysis and renal transplantation in patients with malignant hypertension
S R Acchiardo, W D Black, L Britt, et al.
The American Journal of the Medical Sciences
|
March 1, 1997
Hypotension during hemodialysis: role for nitric oxide
E S Kang, S R Acchiardo, Y B Wang, et al.
The Journal of Laboratory and Clinical Medicine
|
June 13, 2000
Normal circulating adult human red blood cells contain inactive NOS proteins
E S Kang, K Ford, G Grokulsky, et al.
Clinical Nephrology
|
October 30, 2001
A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease
J Lindberg, K J Martin, E A González, et al.
Page
of 5